Anti-VEGF Monoclonal Antibody(Bevacizumab)

產(chǎn)品型號(hào)：S0B0557

更新時(shí)間：2025-10-10

廠商性質(zhì)：生產(chǎn)廠家

訪問量：111

服務(wù)熱線

15855403091

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

蛋白乙酰化研究全攻略：從修飾發(fā)現(xiàn)到功能解析的完整路徑

Anti-RFP/mcherry瓊脂糖珠：純化熒光標(biāo)簽蛋白

sFlt-1：妊娠風(fēng)險(xiǎn)的精準(zhǔn)預(yù)測(cè)因子

神經(jīng)纖維絲輕鏈(NfL)單抗：助力神經(jīng)損傷診斷

產(chǎn)品介紹

Bevacizumab works by blocking a protein called VEGF, which some cancer cells produce in large amounts. Blocking VEGF may prevent the growth of new blood vessels that tumors need to grow. Bevacizumab is a type of targeted therapy called an angiogenesis inhibitor. For cancer, it is given by slow injection into a vein （intravenous） and used for colon cancer, lung cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye （intravitreal）.

上一個(gè)：S0B0558Anti-EGFR Monoclonal Antibody(Cetuximab)